Text Size

A A A

Search


 

 

PBA in Stroke logo


Prevalence, Diagnosis and Treatment of Pseudobulbar Affect in Stroke

A Grand Rounds Activity

This activity is jointly sponsored by Medical Education Resources and National Stroke Association.

Find and register for the program
at your hospital.

Register for this webinar

To learn more about holding a grand rounds activity at your hospital, please contact
Valerie Siebert-Thomas at vsiebert-thomas@stroke.org or call 303-754-0926.

The Program
Pseudobulbar affect (PBA), also referred to as involuntary emotional expression disorder, pathological laughing and crying, or emotional lability, is a neurologic disorder that results in sudden and unpredictable outbursts of crying, laughing or other emotional displays. More than a million people in the U.S. experience PBA; it is one of the most frequently reported post-stroke behavioral syndromes. PBA is underdiagnosed or may be misdiagnosed as depression; therefore, PBA tends to be undertreated or inappropriately treated.

The Prevalence, Diagnosis and Treatment of Pseudobulbar Affect in Stroke grand rounds activity aims to educate healthcare professionals on PBA and why it occurs, current tools used to properly diagnosis the condition, communication with patients and current treatment options.

Participation in this activity is free.

Purpose Statement
To increase clinician knowledge, diagnosis and treatment of PBA after stroke.

Goals and Learning Objectives
The goal of the Prevalence, Diagnosis and Treatment of Pseudobulbar Affect in Stroke grand rounds activity is to increase clinician knowledge, diagnosis and treatment of PBA after stroke. Upon completion of this activity, participants will be able to:

  • Describe the incidence of PBA and its impact on quality of life
  • Report greater competence in diagnosing PBA in stroke survivor patients
  • Express greater confidence in discussing PBA with stroke survivor patients
  • Identify evidence-based and FDA-approved treatments for PBA after stroke
  • Report at least one change to clinical practice relative to discussing PBA with patients, diagnosing PBA or treating PBA in stroke survivor patients

Target Audience
The target audience for the Prevalence, Diagnosis and Treatment of Pseudobulbar Affect in Stroke grand rounds activity includes medical and rehabilitation professionals, including physiatrists, neuropsychologists, physical therapists, occupational therapists, speech therapists and rehabilitation nurses who care for stroke survivors through recovery and rehabilitation. The audience may also include other stroke team members such as neurologists, neuroscience nurses and primary care professionals.

Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and National Stroke Association. MER is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation
Medical Education Resources designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Accreditation
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

This CE activity provides 1 contact hour of continuing nursing education.

Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 1 contact hour.

For questions regarding this activity, please contact Medical Education Resources at info@mer.org or National Stroke Association at vsiebert-thomas@stroke.org.

Disclosure of Conflicts of Interest
MER ensures balance, independence, objectivity and scientific rigor in all its educational programs. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.

The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Faculty
Howard Rosen, MD
University of California, San Francisco

Reported Financial Relationship
Consultant, Avanir Pharmaceuticals, Inc.

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:

Name of Content Manager
Michelle Murdock
Amy Jensen
Lori Conwell, CCMEP

Reported Financial Relationship
No financial relationships to disclose
No financial relationships to disclose
No financial relationships to disclose

View MER’s Privacy Policy.

Back to Top

The Prevalence, Diagnosis and Treatment of Pseudobulbar Affect in Stroke grand rounds activity is supported by an educational grant from Avanir Pharmaceuticals, Inc.

Get Involved

Stroke and You

National Stroke Association

1-800-STROKES
1-800-787-6537
9707 E. Easter Lane, Suite B
Centennial, CO 80112
info@stroke.org